These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12473122)

  • 1. Determinants of antagonist binding at the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit, GluR-D. Role of the conserved arginine 507 and glutamate 727 residues.
    Jouppila A; Pentikäinen OT; Settimo L; Nyrönen T; Haapalahti JP; Lampinen M; Mottershead DG; Johnson MS; Keinänen K
    Eur J Biochem; 2002 Dec; 269(24):6261-70. PubMed ID: 12473122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between agonists and antagonists by the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-selective glutamate receptor. A mutation analysis of the ligand-binding domain of GluR-D subunit.
    Lampinen M; Settimo L; Pentikainen OT; Jouppila A; Mottershead DG; Johnson MS; Keinanen K
    J Biol Chem; 2002 Nov; 277(44):41940-7. PubMed ID: 12167621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand recognition in glutamate receptors: insights from mutagenesis of the soluble alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-binding domain of glutamate receptor type D (GluR-D).
    Keinänen K; Arvola M; Kuusinen A; Johnson M
    Biochem Soc Trans; 1997 Aug; 25(3):835-8. PubMed ID: 9388556
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Li F; Owens N; Verdoorn TA
    Mol Pharmacol; 1995 Jan; 47(1):148-54. PubMed ID: 7838123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the kainate-binding domain of the glutamate receptor GluR-6 subunit.
    Keinänen K; Jouppila A; Kuusinen A
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1461-7. PubMed ID: 9494120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the functional role of the N-glycans in the AMPA receptor ligand-binding domain.
    Pasternack A; Coleman SK; Féthière J; Madden DR; LeCaer JP; Rossier J; Pasternack M; Keinänen K
    J Neurochem; 2003 Mar; 84(5):1184-92. PubMed ID: 12603841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine-481 mutation abolishes ligand-binding of the AMPA-selective glutamate receptor channel alpha1-subunit.
    Kawamoto S; Uchino S; Xin KQ; Hattori S; Hamajima K; Fukushima J; Mishina M; Okuda K
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):339-44. PubMed ID: 9221933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-binding properties and N-glycosylation of alpha 1 subunit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate(AMPA)-selective glutamate receptor channel expressed in a baculovirus system.
    Kawamoto S; Hattori S; Oiji I; Hamajima K; Mishina M; Okuda K
    Eur J Biochem; 1994 Jul; 223(2):665-73. PubMed ID: 7519985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPA receptors and bacterial periplasmic amino acid-binding proteins share the ionic mechanism of ligand recognition.
    Lampinen M; Pentikäinen O; Johnson MS; Keinänen K
    EMBO J; 1998 Aug; 17(16):4704-11. PubMed ID: 9707429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E; Cox JA; Seeburg PH; Verdoorn TA
    Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and conformation of the ligand-binding domain of GluR2 subtype of glutamate receptors.
    Cheng Q; Jayaraman V
    J Biol Chem; 2004 Jun; 279(25):26346-50. PubMed ID: 15100219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface expression of GluR-D AMPA receptor is dependent on an interaction between its C-terminal domain and a 4.1 protein.
    Coleman SK; Cai C; Mottershead DG; Haapalahti JP; Keinänen K
    J Neurosci; 2003 Feb; 23(3):798-806. PubMed ID: 12574408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
    Speranskiy K; Kurnikova M
    Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
    Armstrong N; Sun Y; Chen GQ; Gouaux E
    Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
    Laube B; Schemm R; Betz H
    Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinazolone-alkyl-carboxylic acid derivatives inhibit transmembrane Ca(2+) ion flux to (+)-(S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid.
    Szárics E; Nyikos L; Barabás P; Kovács I; Skuban N; Temesváriné-Major E; Egyed O; Nagy PI; Kökösi J; Takács-Novák K; Kardos J
    Mol Pharmacol; 2001 Apr; 59(4):920-8. PubMed ID: 11259638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
    Clausen RP; Hansen KB; Calí P; Nielsen B; Greenwood JR; Begtrup M; Egebjerg J; Bräuner-Osborne H
    Eur J Pharmacol; 2004 Sep; 499(1-2):35-44. PubMed ID: 15363949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of AMPA receptor desensitization by a point mutation outside the ligand-binding domain.
    Yelshansky MV; Sobolevsky AI; Jatzke C; Wollmuth LP
    J Neurosci; 2004 May; 24(20):4728-36. PubMed ID: 15152033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators.
    Harms JE; Benveniste M; Kessler M; Stone LM; Arai AC; Partin KM
    J Biol Chem; 2014 Apr; 289(15):10702-10714. PubMed ID: 24550387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.